Deficient cell cycle control in myeloid cells of patients with newly diagnosed chronic myeloid leukemia

被引:0
|
作者
Schwab, R [1 ]
Peschel, C [1 ]
Despres, D [1 ]
Derigs, G [1 ]
Fischer, T [1 ]
Huber, C [1 ]
Aulitzky, WE [1 ]
机构
[1] UNIV MAINZ, SCH MED, DEPT MED 3, DIV HEMATOL, D-55101 MAINZ, GERMANY
来源
CYTOKINES AND MOLECULAR THERAPY | 1995年 / 1卷 / 04期
关键词
CML; p53; DNA damage; cell cycle; cip1;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cell cycle control subsequent to gamma irradiation or growth factor starvation has been studied In immative hematopoetic cells of 19 previously untreated chronic myeloid leukemia (CML) patients in chronic phase compared with 18 normal controls. CD34-positive cells were cultured for seven days in the presence of optimal concentrations of appropriate growth factors. At day 7 of culture both S-phase fraction and differentiation were identical in normal and leukemic cells. In normal cells the proportion of S-phase cells was reduced by irradiation with 500 rad from 40 +/- 3% to 16 +/- 2%. In contrast, in CML cells a reduction of S-phase cells from 35 +/- 2% to 25 +/- 3% was observed. Moreover, irradiated CML cells arrested at a smaller number of cells in G2. Similarly, a significantly higher proportion of CML cells remained in S phase after withdrawal of growth factors. Semiquantitative PCR of p21 (waf1/cip1) induction by gamma irradiation provided no evidence for a major functional deficiency of p53 response to irradiation in these cells. Our results demonstrate an abnormal cell cycle arrest in chronic-phase CML cells both after gamma irradiation and after growth factor removal. This observation might have important implications for understanding the pathogenesis of both hyperplasia of chronic phase and the development of blast crisis in CML. The molecular mechanisms underlying these abnormalities in bcr-abl-positive cells remain to be clarified.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 50 条
  • [1] DEFICIENT CELL-CYCLE CONTROL IN IMMATURE HEMATOPOIETIC-CELLS OF PATIENTS WITH NEWLY-DIAGNOSED CHRONIC MYELOID-LEUKEMIA
    AULITZKY, WE
    SCHWAB, R
    PESCHEL, C
    DERIGS, G
    HUBER, C
    [J]. BLOOD, 1994, 84 (10) : A629 - A629
  • [2] Imatinib Mesylate in Newly Diagnosed Patients of Chronic Myeloid Leukemia
    Jacob, L. Abraham
    Bapsy, P. P.
    Babu, K. Govind
    Lokanatha
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 20 - 25
  • [3] Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
    Hochhaus, Andreas
    Wang, Jianxiang
    Kim, Dong-Wook
    Kim, Dennis Dong Hwan
    Mayer, Jiri
    Goh, Yeow-Tee
    le Coutre, Philipp
    Takahashi, Naoto
    Kim, Inho
    Etienne, Gabriel
    Andorsky, David
    Issa, Ghayas C.
    Larson, Richard A.
    Bombaci, Felice
    Kapoor, Shruti
    McCulloch, Tracey
    Malek, Kamel
    Yau, Lillian
    Ifrah, Sophie
    Hoch, Matthias
    Cortes, Jorge E.
    Hughes, Timothy P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [4] Prognostic value of regulatory T cells in newly diagnosed chronic myeloid leukemia patients
    Asmaa M. Zahran
    Hosny Badrawy
    Abeer Ibrahim
    [J]. International Journal of Clinical Oncology, 2014, 19 : 753 - 760
  • [5] Prognostic value of regulatory T cells in newly diagnosed chronic myeloid leukemia patients
    Zahran, Asmaa M.
    Badrawy, Hosny
    Ibrahim, Abeer
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 753 - 760
  • [6] MICRORNAS EXPRESSION IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS IN CHRONIC PHASE
    Fallah, Parviz
    Zamanizadeh, Ayeh
    Obeidi, Narges
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 37 - 37
  • [7] Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia
    O'Brien, SG
    Deininger, MWN
    [J]. SEMINARS IN HEMATOLOGY, 2003, 40 (02) : 26 - 30
  • [8] IMATINIB MESYLATE IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) PATIENTS
    Ionita, H.
    Ionita, I.
    Cheveresan, M.
    Iordache, M.
    Cheveresan, L.
    Ionita, M.
    Borzak, G.
    Ionita, C. O.
    Pascalau, A.
    Calamar, D.
    Oros, D.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 548 - 548
  • [9] Management of patients with newly diagnosed chronic myeloid leukemia: Opportunities and challenges
    Jabbour, Elias
    Cortes, Jorge
    O'Brien, Susan
    Rios, Mary Beth
    Giles, Francis
    Kantarjian, Hagop
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S51 - S57
  • [10] Techniques for risk stratification of newly diagnosed patients with chronic myeloid leukemia
    Mitchell, Birgitta
    Deininger, Michael
    [J]. LEUKEMIA & LYMPHOMA, 2011, 52 : 4 - 11